(Press-News.org) Individuals with psoriasis have a high prevalence of the metabolic syndrome, according to a report posted online today that will appear in the April 2011 print issue of Archives of Dermatology, one of the JAMA/Archives journals.
According to background information in the article, individual features of the metabolic syndrome include obesity, high blood pressure, diabetes and high total cholesterol and triglycerides. Additional background information notes that while past studies have suggested a link between psoriasis and individual components of the metabolic syndrome, there is little data available regarding the association between psoriasis and the metabolic syndrome as a whole.
Using data from the National Health and Nutrition Examination Survey, Thorvardur Jon Love, M.D., of Landspitali University Hospital, Reykjavik, Iceland, and colleagues, examined the association between psoriasis and the metabolic syndrome. The study included 6,549 individuals, and the mean (average) age of participants was 39, half were men and the mean body mass index (BMI) was 28.
Overall, 40 percent of individuals with psoriasis also had features of the metabolic syndrome, compared with 23 percent among controls. The most common feature of the metabolic syndrome among individuals with psoriasis was abdominal obesity (63 percent), followed by high triglyceride levels (44 percent) and low levels of high-density lipoprotein (HDL) or "good" cholesterol (34 percent). High triglyceride levels are defined as at or above 150 milligrams per deciliter, and low HDL levels are defined as less than 40 milligrams per deciliter in men and less than 50 milligrams per deciliter in women. No elements of the metabolic syndrome were found in 28 percent of individuals without psoriasis compared with 13 percent of those with psoriasis.
"In conclusion, these findings from a nationally representative sample of U.S. adults show a doubling in the prevalence of the metabolic syndrome among patients with psoriasis independent of age, sex, race/ethnicity and C-reactive protein levels," the authors write.
"Given its associated serious complications, this comorbidity needs to be recognized and taken into account when treating individuals with psoriasis," they conclude.
INFORMATION:
(Arch Dermatol. Published online December 20, 2010. doi:10.1001/archdermatol.2010.370. Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: This study was supported in part by grants from the National Institute of Health, the Psoriasis Foundation and the National Heart, Lung, and Blood Institute. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
To contact Thorvardur Jon Love, M.D., M.M.Sc., e-mail thorvardur@gmail.com.
For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail mediarelations@jama-archives.org.
Features of the metabolic syndrome common in persons with psoriasis
2010-12-21
ELSE PRESS RELEASES FROM THIS DATE:
About one-fifth of women, less than 7 percent of men report use of indoor tanning
2010-12-21
Women are more likely to report use of indoor tanning facilities than men, and some characteristics common to indoor tanners differ by sex, according to a report in the December issue of Archives of Dermatology, one of the JAMA/Archives journals. However, few tanners—male or female—mention avoiding tanning beds when asked about ways to reduce skin cancer risk.
"Skin cancer is the most common form of malignancy in the United States. The American Cancer Society estimated that 1 million new cases of melanoma and non-melanoma skin cancer were diagnosed in 2009; 8,650 deaths ...
Most patients can speak and swallow after combination treatment for head and neck cancer
2010-12-21
Most patients do not have ongoing speaking or swallowing difficulties following combined chemotherapy and radiation treatment for advanced head or neck cancer, but several factors may be associated with worse outcomes in these functions, according to a report in the December issue of Archives of Otolaryngology–Head & Neck Surgery, one of the JAMA/Archives journals.
"Speaking and swallowing deficits are experienced by many survivors of primary cancers of the head and neck," the authors write as background information in the article. "Although it is often difficult to separate ...
Outcomes after recurrence of oral cancer vary by timing, site
2010-12-21
Patients who have recurrence of oral squamous cell carcinoma tend to do worse if the new cancer appears at the same site early or if it appears in the lymph nodes six months or longer after initial treatment, according to a report in the December issue of Archives of Otolaryngology–Head & Neck Surgery, one of the JAMA/Archives journals.
Treating recurrences of oral squamous cell carcinoma (cancer in the thin, flat cells that line the lips and mouth) involves balancing the risk of complications against the potential benefit to the patient in terms of survival or controlling ...
Study finds injectable and oral birth control do not adversely affect glucose and insulin levels
2010-12-21
GALVESTON, December 17, 2010 – Fasting glucose and insulin levels remain within normal range for women using injectable or oral contraception, with only slight increases among women using depot medroxyprogesterone acetate (DMPA), commonly known as the birth control shot, according to new research from the University of Texas Medical Branch (UTMB Health) in Galveston.
The study, published in the January 2011 issue of Obstetrics and Gynecology and conducted over three years, is the largest to measure fasting glucose and insulin levels among women using DMPA, oral (desogestrel) ...
Factors linked to speech/swallowing problems after treatment for head and neck cancers
2010-12-21
DURHAM, NC – Most patients with locally advanced head and neck cancers who successfully complete treatment with chemotherapy and radiation manage to do so without losing the ability to speak clearly and swallow comfortably, according to researchers at the Duke Cancer Institute.
"This is good news," said Joseph K. Salama, MD, an assistant professor of radiation oncology at Duke and the corresponding author of the study. "I hope it brings some comfort to newly-diagnosed patients who are understandably worried about what long-term effects treatment might involve."
The ...
New research shows virus previously linked to chronic fatigue syndrome is a lab contaminant
2010-12-21
A virus previously thought to be associated with chronic fatigue syndrome is not the cause of the disease, a detailed study has shown. The research shows that cell samples used in previous research were contaminated with the virus identified as XMRV and that XMRV is present in the mouse genome.
XMRV was first linked to chronic fatigue syndrome – also known as myalgic encephalomyelitis (ME) – in a study published in October 2009, where blood samples from chronic fatigue syndrome patients were found to have traces of the virus. XMRV had also been identified previously in ...
Without intervention, Mariana crow to become extinct in 75 years
2010-12-21
Researchers from the University of Washington say the Mariana crow, a forest crow living on Rota Island in the western Pacific Ocean, will go extinct in 75 years.
The extinction could happen almost twice as soon as previously believed.
The crow's extinction can be prevented with a bird management program that focuses on helping fledgling birds reach their first birthday, said James Ha, UW research associate professor in psychology.
Ha examined survival rates in 97 Mariana crows – Corvus kubaryi – that had been tracked between 1990 and 2010 by researchers. He found ...
Finnish researchers find a compound that prevents the growth of prostate cancer cells
2010-12-21
Evidence pointing to the effects of monensin emerged in a project investigating the effects of nearly 5,000 drugs and micromolecules on the growth of prostate cancer cells. The project involved most of the drugs on the market today. Researchers found that small amounts of compounds – disulfiram (Antabus), thiram, tricostatin A, and monensin – can prevent the growth of prostate cancer cells without significant effects on the growth of the normal human prostate epithelial cells.
Further studies revealed that monensin caused prostate cancer cell death by reducing the amount ...
Subsidies have no effect on Spanish cinema productivity
2010-12-21
Awards have an impact on Spanish movie productivity, since they increase internal and external distribution demand, but subsidies have no effect whatsoever on the productivity of the Spanish film industry. This is the conclusion of researchers at the University of Granada (UGR), who have studied the production of films in Spain.
"Awards increase the amount of films produced by increasing productivity. In other words film industry workers and companies are more productive and efficient. However, we did not detect that subsidies had any such effect on productivity", Henry ...
A possible cause -- and cure -- for genital cancer in horses?
2010-12-21
Horses are prone to develop genital cancer, especially as they grow older. Male horses are more commonly affected than mares but both sexes suffer from the condition, which is extremely difficult to treat and may result in the animals' death. Because of the similarity of the disease to human genital cancer it seemed possible that a similar agent might be responsible. Several human genital cancers, including cervical tumours, are known to be caused by a papillomavirus infection, so Brandt and her coworkers used genetic techniques to look for papillomavirus DNA in tissue ...